2019
DOI: 10.1021/acs.jafc.9b01488
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of Hepatic Lipogenesis by Loliolide and Pinoresinol from Lysimachia vulgaris via Degrading Liver X Receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 30 publications
0
13
0
Order By: Relevance
“…The biological activity and chemical composition of secondary metabolites of G. maritima have not yet been determined [34,35]. Species of the Lysimachia genus are used in traditional medicine in East Asia to treat digestive disorders, stop bleeding, and sterilize wounds [36]. Extracts of these plants are known to contain polyphenols [37] and saponins [38].…”
Section: Introductionmentioning
confidence: 99%
“…The biological activity and chemical composition of secondary metabolites of G. maritima have not yet been determined [34,35]. Species of the Lysimachia genus are used in traditional medicine in East Asia to treat digestive disorders, stop bleeding, and sterilize wounds [36]. Extracts of these plants are known to contain polyphenols [37] and saponins [38].…”
Section: Introductionmentioning
confidence: 99%
“…Lysimachia vulgaris (LV) is a medicinal plant traditionally used to treat gastrointestinal conditions, including diarrhea and dysentery, and for hemostasis and wound sterilization (Kim et al, 2019). Recently, in HFD-fed mice, LV extract reduced fat metabolism and restored liver function to control levels.…”
Section: Therapeutic Strategies Targeting Ubl-ptms In Nafldmentioning
confidence: 99%
“…these compounds inhibit fat production by enhancing ubiquitination to increase the degradation of liver X receptors (LXRs). Thus, loliolide and pinoresinol are potential therapeutic candidates for NAFLD as they increase LXR ubiquitination and reduce fat production (Kim et al, 2019).…”
Section: Therapeutic Strategies Targeting Ubl-ptms In Nafldmentioning
confidence: 99%
“…Moreover, LV is a non-toxic, edible plant that grows in Europe, North America, and Asian countries and is registered as a food ingredient in the Korean Food Standards Codex [14]. In a previous study, our research team found that LV is effective in a mouse model of diet-induced obesity, where it induced positive changes in lipid metabolism-related proteins and genes [15]. Moreover, we found some studies showing that Lysimachia christinae (which belongs to the same genus as LV) increased the detoxification mechanisms in liver [16,17].…”
Section: Introductionmentioning
confidence: 99%